慢性肾衰高血压发生率很高,达80％～90％。长期高血压可加速肾功能恶化.因此抗高血压治疗是延缓肾衰进展的主要环节。新型血管紧张素转换酶抑制剂—苯那普利,长效,不含巯基,是一种前体药。在肝脏经酶水解成为活性成份苯那普利拉可抑制血管紧张素转换酶,有治疗肾性高血压及延缓 Chronic renal failure with high incidence of hypertension, up to 80% to 90%. Long-term hypertension can exacerbate renal dysfunction, so antihypertensive treatment is the main link to delay the progression of renal failure. A new angiotensin-converting enzyme inhibitor - benazepril, long-acting, non-mercapto-containing, is a prodrug. Enzymatically hydrolyzed into the active ingredient benazepril in the liver can inhibit angiotensin converting enzyme, the treatment of renal hypertension and delay